Skip to primary navigation
Skip to main content
Skip to footer
Skip to investors navigation

Insmed

Powered by Purpose

Contact Us Job Opportunities

Culture
Our Culture

Mission & Vision

Careers

Responsibility

Inclusion at Insmed

Grants & Funding

Global Healthcare Compliance

Our Global Company
Find available career opportunities in the U.S., Japan, or Europe.
Find Jobs
Patients
Our Patients

Disease Areas

Resources

Patient Access

Current Clinical Trials

You may be eligible for one of our clinical trials.

See if you may qualify
Science
Our Science

Our Pillars

ARIKAYCE^®

Brensocatib

TPIP

Early-Stage Research

Pipeline

Clinical Trials

Investigator-Initiated Research

Our Research
Working together to develop new medicines and technologies that have the potential to transform patients’ lives.
Learn More
About
Investors

Home/Timeline/2013

2013

September 20, 2019 by

Insmed receives Orphan Drug Designation, Qualified Infectious Disease Product designation, and Fast Track status for its lead product candidate.

Footer

Job Opportunities

Our Culture

Our Patients

Our Science

About

Investors
Events & Presentations
Stock Information
News Releases
SEC Filings
Annual Reports
Analyst Coverage
Corporate Governance
Email Alerts
Investor FAQs

© 2022 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
About
Investors

Contact Us Job Opportunities

© 2021 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy